Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Retained Earnings (2021 - 2024)

Opus Genetics (IRD) has disclosed Retained Earnings for 8 consecutive years, with -$76.7 million as the latest value for Q3 2023.

  • On a quarterly basis, Retained Earnings rose 27.27% to -$76.7 million in Q3 2023 year-over-year; TTM through Sep 2023 was -$76.7 million, a 27.27% increase, with the full-year FY2022 number at -$71.5 million, up 20.02% from a year prior.
  • Retained Earnings was -$76.7 million for Q3 2023 at Opus Genetics, up from -$82.2 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$71.5 million in Q4 2022 to a low of -$105.4 million in Q3 2022.
  • A 3-year average of -$84.8 million and a median of -$82.2 million in 2023 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: crashed 33.86% in 2022, then grew 27.27% in 2023.
  • Opus Genetics' Retained Earnings stood at -$89.4 million in 2021, then increased by 20.02% to -$71.5 million in 2022, then dropped by 7.26% to -$76.7 million in 2023.
  • Per Business Quant, the three most recent readings for IRD's Retained Earnings are -$76.7 million (Q3 2023), -$82.2 million (Q2 2023), and -$77.3 million (Q1 2023).